Effect of antisense MBD1 gene eukaryotic expression plasmid on expression of MBD1 gene in human biliary tract carcinoma cells

Abstract

Hypermethylation of the promoter region is one of the major mechanism of tumor suppressor gene inactivation. In order to provide a research tool for the study on the function of MBD1 gene in DNA methylation and tumorigenesis, antisense MBD1 gene eukaryotic expression plasmid was constructed and transfected into human biliary tract carcinoma cell line QBC-939 to observe its effect on the expression of MBD1 mRNA and protein by using RT-PCR and FCM respectively. Following the transfection, the mRNA level of MBD1 gene decreased from 0.912±0.022 to 0.215±0.017, and the protein level of MBD1 gene also decreased from (80.19±5.05) % to (35.11±4.05) %. There were very significant differences in the expression both at the transcription and post-transcription levels of MBD1 gene between non-tranfection group and the antisense MBD1 gene eukaryotic expression plasmid transfection group (P<0.01). It was suggested that transfection with the antisense MBD1 gene cukaryotic expression plasmid can significantly reduce the expression level of MBD1 gene in QBC-939, and this study may provide a valid tool for the investigation of the function of MBD1 gene and its role in biliary tract carcinoma.

Keywords

methyl-CpG binding domain protein 1 / antisense RNA / transfection / gene expression / biliary tract carcinoma

References

[1] DasP M, SingalR. DNA methylation and cancer. J Clin Oncol, 2004, 22(22): 4632-4632

[2] SambrookJ, RussellD W. Translation by Huang Peitang. Molecular Cloning: A Laboratory Manual, 20023rd ed.Beijing, China Science Press: 629-629

[3] WadeP A. Methyl CpG binding proteins: coupling chromatin architecture to gene regulation. Oncogene, 2001, 20(24): 3166-3166

[4] PatraS, PatraA, ZhaoH, et al. . Methyl-CpG-DNA binding proteins in human prostate cancer: expression of CXXC sequence containing MBD1 and repression of MBD2 and MeCP2. Biochem Biophys Res Commun, 2003, 302(4): 759-759

[5] XuX J, LongJ, FuD L, et al. . Analysis of gene expression profiles in pancreatic carcinoma by using cDNA microarray. Hepatobiliary Pancreat Dis Int, 2003, 2(3): 467-467

[6] GaoG, WeiJ M, ZouS Q, et al. . Study of the relationship of alteration and expression of p16 gene and p16 protein on the hilar cholangiocarcinoma. Chin J Gen Surg, 2004, 13(2): 98-98

[7] CrookeS T. Antisense strategies. Curr Mol Med, 2004, 4(5): 465-465

[8] LeeL K, RothC. Antisense technology in molecular and cellular bioengineering. Curr Opin Biotechnol, 2003, 14(5): 505-505